Bugeon L, Cuturi M C, Hallet M M, Paineau J, Chabannes D, Soulillou J P
Institut National de la Santé et de la Recherche Médicale (INSERM U211), Unité de Recherche sur les Effecteurs Lymphocytaires T, Plateau Technique du CHR, Nantes, France.
Transplantation. 1992 Aug;54(2):219-25. doi: 10.1097/00007890-199208000-00006.
Congenic LEW.1W(RT1.u) heart grafts in LEW.1A(RT1.a) recipient rats are rejected in 15 +/- 6 days. Tolerance (greater than 100 days) can be induced by pretransplant donor-specific blood transfusion. In this case, the graft is not rejected, although it is infiltrated by mononuclear cells specifically cytotoxic, in vitro, against allogeneic donor splenocytes. We studied the expression of MHC class I and class II antigens, IFN-gamma, and IL-2 mRNA in the rejected and tolerated grafts by Northern blotting and in situ hybridization. Our data show that both class I and class II mRNA accumulate in both types of graft, and that class I mRNA accumulation occurs more rapidly in the tolerated grafts. IFN-gamma and IL-2 mRNA accumulate to lower levels and with delayed kinetics in the tolerated grafts compared with the rejected ones, suggesting a role for these lymphokines in the mechanism of rejection/tolerance in this model. This hypothesis is also supported by the observation that IFN-gamma treatment abrogates the induction of tolerance in the recipients receiving pretransplant donor blood transfusion. Furthermore, we observed an uncoupling of the accumulation of IFN-gamma mRNA and of MHC class I and class II mRNA. Our data confirm that the mechanisms of tolerance in this model depend, in part, on alterations of the IL-2/IL-2R pathway of lymphocyte activation but also clearly indicate a decrease of IFN-gamma mRNA accumulation, suggesting that the defect involves several activation molecules.
将LEW.1A(RT1.a)受体大鼠的同基因LEW.1W(RT1.u)心脏移植物在15±6天内被排斥。移植前供体特异性输血可诱导耐受(超过100天)。在这种情况下,移植物不会被排斥,尽管它被单核细胞浸润,这些单核细胞在体外对同种异体供体脾细胞具有特异性细胞毒性。我们通过Northern印迹和原位杂交研究了被排斥和耐受移植物中MHC I类和II类抗原、IFN-γ和IL-2 mRNA的表达。我们的数据表明,I类和II类mRNA在两种类型的移植物中均有积累,并且I类mRNA在耐受移植物中的积累更快。与被排斥的移植物相比,IFN-γ和IL-2 mRNA在耐受移植物中的积累水平较低且动力学延迟,这表明这些淋巴因子在该模型的排斥/耐受机制中起作用。IFN-γ处理可消除接受移植前供体输血的受体中的耐受诱导,这一观察结果也支持了这一假设。此外,我们观察到IFN-γ mRNA与MHC I类和II类mRNA的积累出现了解偶联。我们的数据证实,该模型中的耐受机制部分取决于淋巴细胞激活的IL-2/IL-2R途径的改变,但也清楚地表明IFN-γ mRNA积累减少,这表明缺陷涉及多种激活分子。